Uremic toxins circulating in blood of CKD patients lead to endothelial dysfunction and decrease NOS3 abundance, resulting in reduced nitric oxide bioavailability (Harlacher et al., 2022). This evidence concerns the gene NOS3 and endothelial dysfunction.